Cencora, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cencora, Inc. and other ETFs, options, and stocks.

About COR

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. 

CEO
Robert P. Mauch
CEORobert P. Mauch
Employees
51,000
Employees51,000
Headquarters
Conshohocken, Pennsylvania
HeadquartersConshohocken, Pennsylvania
Founded
1947
Founded1947
Employees
51,000
Employees51,000

COR Key Statistics

Market cap
68.51B
Market cap68.51B
Price-Earnings ratio
20.00
Price-Earnings ratio20.00
Dividend yield
0.67%
Dividend yield0.67%
Average volume
1.65M
Average volume1.65M
High today
$359.39
High today$359.39
Low today
$350.11
Low today$350.11
Open price
$350.11
Open price$350.11
Volume
1.22M
Volume1.22M
52 Week high
$377.54
52 Week high$377.54
52 Week low
$244.82
52 Week low$244.82

Stock Snapshot

The current Cencora, Inc.(COR) stock price is $359.03, with a market capitalization of 68.51B. The stock trades at a price-to-earnings (P/E) ratio of 20.00 and offers a dividend yield of 0.67%.

On 2026-11-14, Cencora, Inc.(COR) stock moved within a range of $350.11 to $359.39. With shares now at $359.03, the stock is trading +2.5% above its intraday low and -0.1% below the session's peak.

Trading volume for Cencora, Inc.(COR) stock has reached 1.22M, versus its average volume of 1.65M.

The stock's 52-week range extends from a low of $244.82 to a high of $377.54.

The stock's 52-week range extends from a low of $244.82 to a high of $377.54.

COR News

TipRanks 1d
FTC sues to block Covetrus acquiring MWI from Cencora

The Federal Trade Commission sued to block Covetrus and its owners, Clayton, Dubilier & Rice and TPG Inc., from acquiring its closest competitor, MWI Veterinary...

Reuters 1d
US FTC sues to block Cencora's $3.5 billion sale of veterinary unit to Covetrus - Reuters

...

US FTC sues to block Cencora's $3.5 billion sale of veterinary unit to Covetrus - Reuters
Simply Wall St 3d
Should Profit Rebound Require Action From Cencora Investors?

Cencora reported fourth quarter and full year 2026 results, with sales of US$88.35b for the quarter and US$337.40b for the year, alongside a move from a prior n...

Should Profit Rebound Require Action From Cencora Investors?

Analyst ratings

65%

of 17 ratings
Buy
64.7%
Hold
35.3%
Sell
0%

More COR News

Simply Wall St 5d
Cencora Could Be A Buy For Its Upcoming Dividend

Cencora, Inc. ( ) is about to trade ex-dividend in the next two days. The ex-dividend date is one business day before the record date, which is the cut-off date...

Cencora Could Be A Buy For Its Upcoming Dividend

People also own

Based on the portfolios of people who own COR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.